Phosphagenics Ltd. is a biotechnology company, which engages in the production, sale, and licensing of products for the nutraceuticals and pharmaceutical industries. Its core technology is built around the science and application of Targeted Penetration Matrix (TPM) delivery systems. The technology also improves the oral bioavailability of nutritional actives, such as vitamins. It operates through the following business segments: Production and Personal Care; Human Health; and All Other. The Production and Personal Care segment manufactures and sells TPM and Vital ET. The Human Health segment covers delivery of drugs through gels, injectables, and patches. The All Other segments involves the BioElixia division. The company was founded on June 19, 1992 and is headquartered in Clayton, Australia.